001     137818
005     20240321220324.0
024 7 _ |a 10.1016/j.parkreldis.2014.12.010
|2 doi
024 7 _ |a pmid:25585992
|2 pmid
024 7 _ |a pmc:PMC4408541
|2 pmc
024 7 _ |a 1353-8020
|2 ISSN
024 7 _ |a 1873-5126
|2 ISSN
024 7 _ |a altmetric:3069883
|2 altmetric
037 _ _ |a DZNE-2020-04140
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ortega-Cubero, Sara
|b 0
245 _ _ |a TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study.
260 _ _ |a Amsterdam [u.a.]
|c 2015
|b Elsevier Science
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2015-03-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1705936269_13660
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Essential tremor (ET) is the most frequent movement disorder in adults. Its pathophysiology is not clearly understood, however there is growing evidence showing common etiologic factors with other neurodegenerative disorders such as Alzheimer's and Parkinson's diseases (AD, PD). Recently, a rare p.R47H substitution (rs75932628) in the TREM2 protein (triggering receptor expressed on myeloid cells 2; OMIM: *605086) has been proposed as a risk factor for AD, PD and amyotrophic lateral sclerosis (ALS). The objective of the study was to determine whether TREM2 p.R47H allele is also a risk factor for developing ET.This was a cross-sectional multicenter international study. An initial case-control cohort from Spain (n = 456 ET, n = 2715 controls) was genotyped. In a replication phase, a case-control series (n = 897 ET, n = 1449 controls) from different populations (Italy, Germany, North-America and Taiwan) was studied. Owed to the rarity of the variant, published results on p.R47H allele frequency from 14777 healthy controls from European, North American or Chinese descent were additionally considered. The main outcome measure was p.R47H (rs75932628) allelic frequency.There was a significant association between TREM2 p.R47H variant and ET in the Spanish cohort (odds ratio [OR], 5.97; 95% CI, 1.203-29.626; p = 0.042), but it was not replicated in other populations.These results argue in favor of population-specific differences in the allelic distribution and suggest that p.R47H (rs75932628) variant may contribute to the susceptibility of ET in Spanish population. However, taking into account the very low frequency of p.R47H, further confirmatory analyses of larger ET series are needed.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
542 _ _ |i 2015-03-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Membrane Glycoproteins
|2 NLM Chemicals
650 _ 7 |a Receptors, Immunologic
|2 NLM Chemicals
650 _ 7 |a TREM2 protein, human
|2 NLM Chemicals
650 _ 7 |a Histidine
|0 4QD397987E
|2 NLM Chemicals
650 _ 7 |a Arginine
|0 94ZLA3W45F
|2 NLM Chemicals
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Arginine: genetics
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a DNA Mutational Analysis
|2 MeSH
650 _ 2 |a Essential Tremor: etiology
|2 MeSH
650 _ 2 |a Essential Tremor: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease
|2 MeSH
650 _ 2 |a Genotype
|2 MeSH
650 _ 2 |a Germany
|2 MeSH
650 _ 2 |a Histidine: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a International Cooperation
|2 MeSH
650 _ 2 |a Italy
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Membrane Glycoproteins: genetics
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a North America
|2 MeSH
650 _ 2 |a Receptors, Immunologic: genetics
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Spain
|2 MeSH
650 _ 2 |a Taiwan
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Lorenzo-Betancor, Oswaldo
|b 1
700 1 _ |a Lorenzo, Elena
|b 2
700 1 _ |a Agúndez, José A G
|b 3
700 1 _ |a Jiménez-Jiménez, Félix J
|b 4
700 1 _ |a Ross, Owen A
|b 5
700 1 _ |a Wurster, Isabel
|0 P:(DE-2719)2812736
|b 6
|u dzne
700 1 _ |a Mielke, Carina
|0 P:(DE-2719)9000213
|b 7
|u dzne
700 1 _ |a Lin, Juei-Jueng
|b 8
700 1 _ |a Coria, Francisco
|b 9
700 1 _ |a Clarimon, Jordi
|b 10
700 1 _ |a Ezquerra, Mario
|b 11
700 1 _ |a Brighina, Laura
|b 12
700 1 _ |a Annesi, Grazia
|b 13
700 1 _ |a Alonso-Navarro, Hortensia
|b 14
700 1 _ |a García-Martin, Elena
|b 15
700 1 _ |a Gironell, Alex
|b 16
700 1 _ |a Marti, Maria J
|b 17
700 1 _ |a Yueh, Kuo-Chu
|b 18
700 1 _ |a Wszolek, Zbigniew K
|b 19
700 1 _ |a Sharma, Manu
|0 P:(DE-2719)9000296
|b 20
|u dzne
700 1 _ |a Berg, Daniela
|0 P:(DE-2719)2000059
|b 21
|u dzne
700 1 _ |a Krüger, Rejko
|0 P:(DE-2719)2811170
|b 22
|u dzne
700 1 _ |a Pastor, Maria A
|b 23
700 1 _ |a Pastor, Pau
|0 P:(DE-HGF)0
|b 24
|e Corresponding author
773 1 8 |a 10.1016/j.parkreldis.2014.12.010
|b : Elsevier BV, 2015-03-01
|n 3
|p 306-309
|3 journal-article
|2 Crossref
|t Parkinsonism & Related Disorders
|v 21
|y 2015
|x 1353-8020
773 _ _ |a 10.1016/j.parkreldis.2014.12.010
|g Vol. 21, no. 3, p. 306 - 309
|0 PERI:(DE-600)2027635-7
|n 3
|q 21:3<306 - 309
|p 306-309
|t Parkinsonism & related disorders
|v 21
|y 2015
|x 1353-8020
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408541
856 4 _ |u https://pub.dzne.de/record/137818/files/DZNE-2020-04140_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/137818/files/DZNE-2020-04140_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:137818
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2812736
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9000213
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)9000296
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2000059
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2811170
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 0
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PARKINSONISM RELAT D : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)1240004
|k Biobanking Facility Tübingen
|l Biobanking Facility Tübingen
|x 0
920 1 _ |0 I:(DE-2719)5000058
|k Ext UKT
|l Ext Universitätsklinikum Tübingen
|x 1
920 1 _ |0 I:(DE-2719)5000057
|k Ext HIH
|l Ext Hertie-Institut für klinische Hirnforschung
|x 2
920 1 _ |0 I:(DE-2719)5000055
|k AG Berg ; AG Berg
|l Parkinson's Disease Genetics
|x 3
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1240004
980 _ _ |a I:(DE-2719)5000058
980 _ _ |a I:(DE-2719)5000057
980 _ _ |a I:(DE-2719)5000055
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21